William Saunderson-Meyer on Ivermectin as an alternative for Covid

Loading player...
William Saunderson-Meyer outlines the contradictories in research around Ivermectin all around the world. The drug has become one of most hotly debated topics over the last twelve months, given its apparent miracle-like effects at preventing Covid-19, despite full clinical trials having not been conducted. Learn more about your ad choices. Visit megaphone.fm/adchoices
1 Jul 2021 9AM English South Africa Investing · Business News

Other recent episodes

BN Daybreak - Fri 22 May 2026: Zille slams Joburg budget; Roodt on Crypto; Hoatson urges pushback; and Gupta delays

In today's BizNews Daybreak, we cover the latest business and political updates. On the international front, US-Iran tensions escalate over Strait of Hormuz tolls, while SpaceX scrubs its 12th Starship test mission. Locally, Helen Zille warns of Johannesburg’s collapsing municipal budget and failing infrastructure, economist Dawie Roodt discusses Treasury's futile…
21 May 11PM 15 min

Jacques Broodryk - AfriForum goes after the elusive Guptas…

AfriForum has asked the National Director of Public Prosecutions, Advocate Andy Mothibi, for an urgent update on the much delayed extradition of the Guptas who allegedly benefited from State Capture to the tune of between R50 and R70 billion. In this interview with Chris Steyn, Jacques Broodryk, AfriForum’s Chief Spokesperson:…
21 May 5AM 9 min

BN Daybreak - Thu 21 May 2026: Nvidia; SpaceX; Anthropic; Fed Hikes; Oil Shock; SA Infrastructure; Hartley on BRICS

In today's BizNews Daybreak, Nvidia delivers an upbeat sales forecast and multi-billion-dollar buyback plan, while SpaceX prepares for the world’s largest ever IPO. Meanwhile, Anthropic reports surging Claude revenue, and Fed minutes signal potential interest rate hikes. In global affairs, Middle East tensions cause oil market volatility, raising economic risks…
20 May 11PM 12 min